DNMT1 and neoplasm: In this manner, their findings propose an innovative regulatory pathway involving miR‐148a/152 and DNMT1, highlighting the tumour suppressive roles of miR‐148a and miR‐152 by targeting IGF‐IR and IRS1 [91].